Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

723 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.
Silkenstedt E, Arenas F, Colom-Sanmartí B, Xargay-Torrent S, Higashi M, Giró A, Rodriguez V, Fuentes P, Aulitzky WE, van der Kuip H, Beà S, Toribio ML, Campo E, López-Guerra M, Colomer D. Silkenstedt E, et al. Among authors: higashi m. J Exp Clin Cancer Res. 2019 Nov 1;38(1):446. doi: 10.1186/s13046-019-1458-7. J Exp Clin Cancer Res. 2019. PMID: 31676012 Free PMC article.
Potential utility of serum soluble LR11 as a diagnostic biomarker for intravascular large B-cell lymphoma.
Kawaguchi T, Ohwada C, Takeuchi M, Shimizu N, Sakaida E, Takeda Y, Sakai S, Tsukamoto S, Yamazaki A, Sugita Y, Higashi M, Fujikawa K, Matsue K, Yokote K, Tamaru J, Bujo H, Nakaseko C. Kawaguchi T, et al. Among authors: higashi m. Leuk Lymphoma. 2014 Oct;55(10):2391-4. doi: 10.3109/10428194.2014.880430. Epub 2014 Mar 7. Leuk Lymphoma. 2014. PMID: 24401112 No abstract available.
Serum soluble LR11, a novel tumor derived biomarker associated with the outcome of patients with diffuse large B-cell lymphoma.
Ohwada C, Yamazaki A, Kawaguchi T, Sugita Y, Takeuchi M, Shimizu N, Sakaida E, Takeda Y, Tsukamoto S, Muto T, Jiang M, Higashi M, Yokote K, Tamaru J, Bujo H, Nakaseko C. Ohwada C, et al. Among authors: higashi m. Leuk Lymphoma. 2015;56(10):2982-5. doi: 10.3109/10428194.2015.1016930. Epub 2015 Mar 11. Leuk Lymphoma. 2015. PMID: 25676033 No abstract available.
[De novo blast phase of chronic myeloid leukemia with 3q26 abnormality diagnosed by cytogenetic analysis of extramedullary lesion].
Matsunaga T, Naganuma K, Tabayashi T, Kawada T, Sakata N, Takahashi Y, Kimura Y, Anan T, Mitsuhashi T, Kubota Y, Sawada K, Yamashita T, Momose S, Higashi M, Tamaru JI, Kizaki M. Matsunaga T, et al. Among authors: higashi m. Rinsho Ketsueki. 2022;63(12):1643-1647. doi: 10.11406/rinketsu.63.1643. Rinsho Ketsueki. 2022. PMID: 36653137 Japanese.
CD44 suppresses TLR-mediated inflammation.
Kawana H, Karaki H, Higashi M, Miyazaki M, Hilberg F, Kitagawa M, Harigaya K. Kawana H, et al. Among authors: higashi m. J Immunol. 2008 Mar 15;180(6):4235-45. doi: 10.4049/jimmunol.180.6.4235. J Immunol. 2008. PMID: 18322236
723 results